430 patents currently held
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
16 more records may belong here and await a decision; they are not counted.
The next term ends in Jan 2027. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
101
Ending by 2030
Jan 2027
Next term end
232
Patent families
When these terms end
Held patents by the year their term ends
notable patents
fee due within 90 days
all others
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size. Fee due within 90 days: a maintenance fee is due within 90 days of when this page was computed and not yet paid.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Jun 2030 · High confidence
Also notable
Ends Oct 2027 · High confidence
Also notable
Ends Nov 2034 · High confidence
Fluid Component Analysis System and Method for Glucose Monitoring and Control
US 8,417,311
Cited by 333 later US patents, top 1% of utility patents granted in 2013 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2030.
Disposable, Wearable Insulin Dispensing Device, a Combination of Such a Device and a Programming Controller and a Method of Controlling the Operation of Such a Device
US 7,785,288
Cited by 466 later US patents, top 1% of utility patents granted in 2010 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2027.
Infusion Pump System and Methods
US 11,260,169
Cited by 51 later US patents, top 5% of utility patents granted in 2022 in our data. Protection runs to 2034.
Formerly held, still cited
Notable
Ends Dec 2033 · Medium confidence
Cited by 104 later US patents, top 5% of utility patents granted in 2018 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2033.
now held by Sanvita Medical Corporation
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 30, 2026The maintenance fee for Semi-Rigid and Flexible Elements for Wearable Drug Delivery Device Reservoir (US 11,660,389) comes due Nov 30, 2026. Unpaid by Jun 1, 2027, it lapses early.
- 6 fees due Dec 4 to 27, 2026 · next Dec 4
- 7 fees due Jan 2 to 30, 2027 · next Jan 2
- 6 fees due Feb 13 to 28, 2027 · next Feb 13
- 7 fees due Mar 5 to 26, 2027 · next Mar 5
- 9 fees due Apr 8 to 30, 2027 · next Apr 8
- 1 fee due May 21, 2027The maintenance fee for Needle Mechanism Module for Drug Delivery Device (US 11,819,675) comes due May 21, 2027. Unpaid by Nov 22, 2027, it lapses early.
- 3 fees due Jun 5 to 10, 2027 · next Jun 5
- 4 fees due Jul 2 to 30, 2027 · next Jul 2
- 6 fees due Aug 16 to 27, 2027 · next Aug 16
- 9 fees due Sep 3 to 30, 2027 · next Sep 3
- 9 fees due Oct 5 to 30, 2027 · next Oct 5
Recent changes
- 29 of the patents on this record were granted since Aug 18, 2026
- 18 terms have ended since Aug 18, 2026
What they patent
The 5 largest of its 232 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Fluid Injection and Safety System | 12 in force | to Jun 2032 |
| Fluid Delivery Device, Transcutaneous Access Tool and Insertion Mechanism for Use Therewith | 8 in force | to Dec 2036 |
| Infusion Pump Systems and Methods | 7 in force | to May 2029 |
| Operating an Infusion Pump System | 7 in force | to Oct 2028 |
| Activity Sensing Techniques for an Infusion Pump System | 7 in force | to Feb 2028 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,922,708 | Operating an Infusion Pump System In force · High confidence | In force | High confidence | |
| US 7,794,428 | Operating an Infusion Pump System In force · Medium confidence | In force | Medium confidence | |
| US 9,114,209 | Method and System for Manual and Autonomous Control of an Infusion Pump In force · High confidence | In force | High confidence | |
| US 8,551,046 | Dispensing Fluid from an Infusion Pump System In force · High confidence | In force | High confidence | |
| US 8,622,966 | Operating an Infusion Pump System In force · High confidence | In force | High confidence | |
| US 9,872,957 | Operating an Infusion Pump System In force · High confidence | In force | High confidence | |
| US 10,307,536 | Operating an Infusion Pump System In force · High confidence | In force | High confidence | |
| US 8,696,633 | Operating an Infusion Pump System In force · High confidence | In force | High confidence | |
| US 7,789,859 | Operating an Infusion Pump System In force · Medium confidence | In force | Medium confidence | |
| US 8,152,765 | Infusion Pump System with Contamination-Resistant Features In force · High confidence | In force | High confidence |
Also on record, not counted in the 430: 4 patents in force now held by others · 56 patents ended · 213 applications pending · 54 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Fee due within 90 days marks a patent with a maintenance fee due within 90 days of the date this page was computed and not yet recorded paid, so it can end earlier than the bar shows. A fee left unpaid ends the patent at the close of the six month grace period that follows its due date, not on the due date itself. It is not a prediction that the fee will be missed.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.